Women's Health Issues
Volume 19, Issue 5 , Pages 325-334 , September 2009

Maternal Depressive Symptoms, Depression, and Psychiatric Medication Use in Relation to Risk of Preterm Delivery

  • Amelia R. Gavin, PhD, MSW

      Affiliations

    • University of Washington, School of Social Work, Seattle, Washington
    • Corresponding Author InformationCorrespondence to: Amelia R. Gavin, University of Washington, School of Social Work, 4101 15th Avenue NE, Box 354900, Seattle, Washington, 98105, Phone: 206-616-8847; Fax: 206-543-1228.
    • ,
  • Claudia Holzman, DVM, MPH, PhD

      Affiliations

    • Michigan State University, Department of Epidemiology, East Lansing, Michigan
    • ,
  • Kristine Siefert, PhD, MPH

      Affiliations

    • University of Michigan, School of Social Work, Ann Arbor, Michigan
    • ,
  • Yan Tian, MS

      Affiliations

    • Michigan State University, Department of Epidemiology, East Lansing, Michigan

Received 19 August 2008 ,Revised 29 April 2009 ,Accepted 29 May 2009.

References 

  1. Adler J, Fink N, Bitzer J, Hosli I, Holzgreve W. Depression and anxiety during pregnancy: A risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. Journal of Maternal-Fetal & Neonatal Medicine. 2007;20:189–209
  2. Ananth D, Vintzileos A. Medically indicated preterm birth: Recognizing the importance of the problem. Clinics in Perinatology. 2008;35:53–67
  3. Andersson L, Sundstrom-Poromaa I, Wulff M, Astrom M, Bixo M. Neonatal Outcome following maternal antenatal depression and anxiety: A population-based study. Journal of Epidemiology. 2004;159:872–881
  4. Austin M, Leader L. Maternal stress and obstetric and infant outcomes: epidemiological findings and neuroendocrine mechanisms. Australian & New Zealand Journal of Obstetrics & Gynaecology. 2000;40:331–337
  5. Behrman R, Butler A. Preterm birth: Causes, consequences, and prevention. Washington, D.C: National Academies Press; 2006;
  6. Berle J, Mykletun A, Daltveit A, Rasmussen S, Holsten F, Dahl A. Neonatal outcomes in offspring of women with anxiety and depression during pregnancy. Archives of Women's Mental Health. 2005;8:181–189
  7. Callaghan W, MacDorman M, Rasmussen M, Qin C, Lackritz E. The contribution of preterm births to infant mortality rates in the United States. Pediatrics. 2006;118:1566–1573
  8. Cooper R, Goldenberg R, Das A, Elder N, Swain M, Norman G, et al. The preterm prediction study: Maternal stress is associated with spontaneous preterm birth at less than thirty-five weeks' gestation. American Journal of Obstetrics and Gynecology. 1996;175:1286–1292
  9. Davis R, Rubanowixe D, McPhillips H, Raebel M, Andrade S, Smith D, et al. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiology and Drug Safety. 2007;16:1086–10942007
  10. Dayan J, Creveuil C, Marks M, Conroy S, Herlicoviez M, Dreyfus M, et al. Prenatal depression, prenatal anxiety, and spontaneous preterm birth: A prospective cohort study among women with early and regular care. Psychosomatic Medicine. 2006;68:938–946
  11. Dole N, Savitz D, Siega-Ruiz A, Hertz-Picciotto I, McMahon M, Buekens P. Psychosocial factors and preterm birth among African American and white women in Central North Carolina. American Journal of Public Health. 2004;94:1358–1365
  12. Dole N, Savitz D, Hertz-Picciotto I, Siega-Ruiz A, McMahon M, Buekens P. Maternal stress and preterm birth. Journal of Epidemiology. 2003;157:14–24
  13. Hasin D, Goodwin R, Stinson F, Grant B. Epidemiology of major depressive disorder. Archives of General Psychiatry. 2005;62:1097–1106
  14. Hedegaard M, Henriksen T, Secher N, Hatch M, Sabroe S. Do stressful life events affect duration of gestation and risk of preterm delivery?. Epidemiology. 1996;7:339–3451996
  15. Hendrick V, Stowe Z, Altshuler L, Hwang S, Lee E, Haynes D. Placental passage of antidepressant medications. American Journal of Psychiatry. 2003;160:993–996
  16. Hoffman S, Hatch M. Stress, social support and pregnancy outcome: A reassessment based on recent research. Paediatric and Perinatal Epidemiology. 1996;10:380–405
  17. Hoffman S, Hatch M. Depressive symptomatology during pregnancy: Evidence for an association with decreased fetal growth in pregnancies of lower social class women. Health Psychology. 2000;19:535–543
  18. Huffman L, Lamour M, Bryan Y, Pederson F. Depressive symptomology during pregnancy and the postpartum period: Is the Beck Depression Inventory applicable?. Journal of Reproductive and Infant Psychology. 1990;8:87–97
  19. Iams J, Goldenberg R, Mercer B, Moawad A, Meis P, Das A, et al. The preterm prediction study: Can low-risk women destined for spontaneous preterm birth be identified?. American Journal of Obstetrics and Gynecology. 2001;184:652–655
  20. Kelly R, Holzman C, Senagore P, Wang J, Tian Y, Rahbar MH, et al. Placental vascular pathology findings and pathways to preterm delivery. American Journal of Epidemiology. 2009;June 9 [Epub ahead of press]
  21. Larsson C, Sydsjo G, Josefsson A. Health, sociodemographic data, and pregnancy outcome in women with antepartum depressive symptoms. Obstetrics and Gynecology. 2004;104:459–466
  22. Li D, Liu L, Odouli R. Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: A prospective cohort study. Human Reproduction. 2008;24:146–153
  23. Lin E, Katon W, VonKorff M, Russo J, Simon G, Bush T, et al. Relapse of depression in primary care. Archives of Family Medicine. 1998;7:43–49
  24. Looper K. Potential medical and surgical complications of serotonergic antidepressant medications. Psychosomatics. 2007;48:1–9
  25. Loughhead A, Fisher A, Newport DJ, Ritchie J, Owens M, DeVane CL, et al. Antidepressants in amniotic fluid: another route of fetal exposure. American Journal of Psychiatry. 2006;163:145–147
  26. Meis P, Goldenberg R, Mercer B, Iams J, Moawad A, Miodovnick M, et al. The preterm prediction study: Risk factors for indicated preterm births. American Journal of Obstetrics and Gynecology. 1998;178:562–567
  27. Mercer B, Goldenberg R, Moawad A, Meis P, Iams J, Das A, et al. The preterm prediction study: Effect of gestational age and cause of preterm birth on subsequent obstetric outcome. American Journal of Obstetrics and Gynecology. 1999;181:1216–1221
  28. Mitchell A, Coyne J. Do ultra-short screening instruments accurately detect depression in primary care? A pooled analysis and meta-analysis of 22 studies. British Journal of General Practice. 2007;57:144–151
  29. Moses-Kolko E, Bogen D, Perel J, Bregar A, Uhl K, Levin B, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: Literature review and implications for clinical applications. Journal of the American Medical Association. 2005;293:2372–2382
  30. Moutquin J. Classification and heterogeneity of preterm birth. BJOG: International Journal of Obstetrics and Gynaecology. 2003;110:30–33
  31. Mustillo S, Krieger N, Gunderson E, Sidney S, McCreath H, Kiefe C. Self-reported experiences of racial discrimination and black-white differences in preterm and low-birthweight deliveries: The CARDIA study. American Journal of Public Health. 2004;94:2125–2131
  32. Neggers Y, Goldenberg R, Cliver S, Hauth J. The relationship between psychosocial profile, health practices, and pregnancy outcomes. Acta Obstetricia et Gynecologica Scandinavica. 2006;85:277–285
  33. Nierenberg A, Petersen T, Alpert J. Prevention of relapse and recurrence in depression: The role of long-term pharmacotherapy and psychotherapy. Journal of Clinical Psychiatry. 2003;64(Suppl 15):13–17
  34. Oberlander T, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Archives of General Psychiatry. 2006;63:898–906
  35. Oberlander T, Warburton W, Misri S, Aghajanian J, Hertzman C. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: Population-based study. British Journal of Psychiatry. 2008;193:338–343
  36. Orr S, Miller C. Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings. Epidemiological Reviews. 1995;17:165–171
  37. Orr S, James SA, Blackmore-Prince C. Maternal prenatal depressive mood and spontaneous preterm births among African-American women in Baltimore, Maryland. American Journal of Epidemiology. 2002;156:797–802
  38. Paulose-Ram R, Safran M, Jonas B, Gu Q, Orwig D. Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiology and Drug Safety. 2007;16:560–570
  39. Pekin M, Bland J, Peacock J, Anderson H. The effect of anxiety and depression during pregnancy on obstetric complications. British Journal of Obstetrics and Gynaecology. 1993;100:629–634
  40. Radloff L. The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement. 1977;1:384–401
  41. Radloff L, Locke B. The community mental health assessment survey and CES-D scale. In:  Weissman MM,  Myers JK editor. Community surveys of psychiatric disorders. New Brunswick, NJ: Rutgers University Press; 1986;
  42. Raghunathan T, Lepkowski J, Van Hoewyk J, Solenberger P. A multivariate technique for multiple imputing missing values using a sequence of regression models. Survey Methodology. 2001;27:85–95
  43. Simon G, Cunningham M, Davis R. Outcomes of prenatal antidepressant exposure. American Journal of Psychiatry. 2002;159:2055–2061
  44. Spong C. No easy answers for predicting preterm labor. Obstetrics and Gynecology. 2002;100:219–220
  45. Steer R, Scholl T, Hediger M, Fischer R. Self-reported depression and negative pregnancy outcomes. Journal of Clinical Epidemiology. 1992;45:1093–1099
  46. Suri R, Hellemann G, Cohen L, Aquino A, Altshuler L. Saliva estriol levels in women with and without prenatal antidepressant treatment. Biological Psychiatry. 2008;64:533–537
  47. Suri R, Altshuler L, Hellemann G, Burt VK, Aquino A, Mintz J. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. American Journal of Psychiatry. 2007;164:1206–1213
  48. Wadhwa P, Sandman C, Porto M, Dunkel-Schetter C, Garite T. The association between prenatal stress and infant birth weight and gestational age at birth: A prospective investigation. American Journal of Obstetrics and Gynecology. 1993;169:858–865
  49. Wen S, Yang Q, Garner P, Fraser W, Olatunbosum O, Nimrod C, et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. American Journal of Obstetrics and Gynecology. 2006;194:961–966
  50. Whooley M, Avins A, Miranda J, Browner W. Case-finding instruments for depression: Two questions are as good as many. Journal of General Internal Medicine. 1997;12:439–445

 This publication was made possible by Grant Number 1KL2RR025015-01 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. Additional sources of financial support include the National Institute of Child Health and Human Development grant number R01 HD034543, National Institute of Nursing Research (Renewal NIH POUCH) grant number R01 HD34543, March of Dimes Foundation (Perinatal Epidemiological Research Initiative Program) Grants 20-FY98-0697 through 20-FY04-37, Thrasher Research Foundation grant 02816-7 and Centers for Disease Control and Prevention grant U01 DP000143-01.

PII: S1049-3867(09)00056-5

doi: 10.1016/j.whi.2009.05.004

Women's Health Issues
Volume 19, Issue 5 , Pages 325-334 , September 2009

Article Tools